Diagnostic Testing for Chronic Chest Pain with Normal ECG
For patients with chronic stable chest pain and a normal resting ECG, you should first estimate their pre-test probability of obstructive coronary artery disease (CAD) using the Risk Factor-weighted Clinical Likelihood model, then proceed with coronary computed tomography angiography (CCTA) for intermediate-high risk patients (>15% likelihood) or consider coronary artery calcium (CAC) scoring for low-risk patients (<15% likelihood). 1, 2
Initial Risk Stratification
The 2024 ESC guidelines mandate using the Risk Factor-weighted Clinical Likelihood model to categorize patients into low (<5%), moderate (5-50%), or high (>50%) pre-test probability of obstructive CAD 1. This model should be adjusted using additional clinical data including peripheral artery examination findings, resting echocardiography results, and presence of vascular calcifications on prior imaging 1.
Essential Basic Testing
Before proceeding with cardiac imaging, obtain these blood tests to refine risk stratification and identify comorbidities 1:
- Lipid profile (including LDL-C)
- Complete blood count (hemoglobin)
- Creatinine with eGFR calculation
- HbA1c and/or fasting glucose
- Thyroid function (at least once)
Resting Echocardiography
A resting transthoracic echocardiogram is recommended for all patients to 1:
- Measure left ventricular ejection fraction, volumes, and diastolic function
- Identify regional wall motion abnormalities
- Exclude non-coronary cardiac disease (cardiomyopathy, valve disease, pericardial effusion)
- Assess right ventricular function and pulmonary artery pressure
This is particularly critical for patients with pathological Q waves, heart failure symptoms, complex arrhythmias, or heart murmurs 2.
Risk-Based Imaging Strategy
Low-Risk Patients (>5-15% pre-test probability):
CAC scoring is reasonable as a first-line test to exclude calcified plaque and identify patients with low likelihood of obstructive CAD 2. A CAC score of zero effectively excludes significant CAD and identifies patients with favorable prognosis who can defer additional testing 2.
Alternatively, exercise ECG without imaging is reasonable for low-risk patients with interpretable ECG and ability to exercise, primarily to assess exercise tolerance, symptoms, arrhythmias, and blood pressure response 1, 2. However, the 2024 ESC guidelines explicitly state that exercise ECG is not recommended for diagnostic purposes to rule out CAD if CCTA or functional imaging is available 1.
Intermediate-High Risk Patients (>15-85% pre-test probability):
CCTA is the recommended first-line test (Class I, Level A evidence) for diagnosis of obstructive CAD, risk stratification, and guiding treatment decisions 1, 2. Both the 2024 ESC and 2021 ACC/AHA guidelines strongly endorse CCTA for this population, with the ESC specifically recommending it for moderate pre-test probability (>5-50%) 1.
Contraindications to CCTA include 1:
- Severe renal failure (eGFR <30 mL/min/1.73 m²)
- Decompensated heart failure
- Extensive coronary calcification
- Fast irregular heart rate
- Severe obesity
- Inability to cooperate with breath-hold commands
Alternative: Stress Imaging
Stress imaging (stress echocardiography, PET/SPECT myocardial perfusion imaging, or cardiac MRI) is equally effective for intermediate-high risk patients to diagnose myocardial ischemia and estimate risk of major adverse cardiac events 1, 2.
For stress echocardiography, use intravenous ultrasound contrast agents (microbubbles) when two or more contiguous segments are not visualized, and consider contrast-enhanced myocardial perfusion to improve diagnostic accuracy 1.
If nuclear imaging is selected, PET is preferred over SPECT when available to improve diagnostic accuracy and decrease nondiagnostic results 2.
Sequential Testing Strategy
If CCTA reveals coronary stenosis of 40-90% in a proximal or middle segment, FFR-CT is useful for diagnosing vessel-specific ischemia and guiding revascularization decisions 2.
If CCTA is inconclusive or nondiagnostic, proceed with stress imaging 2.
If stress testing is inconclusive or abnormal, CCTA is reasonable as a follow-up test 2.
Common Pitfalls to Avoid
Do not order exercise ECG for patients with 1:
- ≥0.1 mV ST-segment depression on resting ECG
- Left bundle branch block
- Digitalis therapy
Do not rely on exercise ECG alone for diagnostic purposes in the modern era when CCTA or functional imaging is available 1.
Ambulatory ECG monitoring should be reserved specifically for patients with suspected arrhythmias as the cause of chest pain 1.
Evidence Quality Note
The 2024 ESC guidelines represent the most current evidence and provide the strongest recommendation (Class I, Level A) for CCTA in the appropriate risk population 1. The 2021 ACC/AHA guidelines concordantly support this approach 2. The convergence of these major international guidelines on CCTA as first-line testing for intermediate-risk patients reflects robust evidence from multiple randomized trials demonstrating its effectiveness for diagnosis, risk stratification, and guiding treatment decisions 1, 2.